New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials.
Author:
Affiliation:
1. Editor-in-Chief, Oslo University Hospital Ullevål and Institute of Clinical Sciences, University of Oslo , 0450 Oslo , Norway
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Link
https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvac019/43391003/pvac019.pdf
Reference20 articles.
1. Dosage of direct oral anticoagulants during dual and triple antithrombotic therapy: a focus on the net clinical benefit;Kazem;European Heart Journal - Cardiovascular Pharmacotherapy,2021
2. Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith;Galli;European Heart Journal - Cardiovascular Pharmacotherapy,2021
3. Aspirin-omitted dual antithrombotic therapy in non-valvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis;Luo;European Heart Journal - Cardiovascular Pharmacotherapy,2021
4. Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter;Rubboli;European Heart Journal - Cardiovascular Pharmacotherapy,2021
5. Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin k antagonist oral anticoagulant-based randomized clinical trials;Gargiulo;Eur Heart J Cardiovasc Pharmacother,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The search for the perfect antiplatelet treatment continues;European Heart Journal - Cardiovascular Pharmacotherapy;2023-12
2. Cardiovascular preventive actions;European Heart Journal - Cardiovascular Pharmacotherapy;2023-09
3. Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?;European Heart Journal - Cardiovascular Pharmacotherapy;2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3